The symptoms of tyrosinemia type III are poorly understood, and there is no clear link between tyrosine serum levels, clinical presentation, and mutation type. Many patients have neurodevelopmental manifestations such as intellectual impairment, learning difficulties, dyslexia, attention deficit, hyperactivity, behavioral disturbance, ataxia, micro